PB Fintech Board Approves Re-appointments, New Director & Audit Committee Reconstitution

5 min read     Updated on 13 May 2026, 10:47 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

PB Fintech Limited's board meeting on May 11, 2026 resulted in multiple governance approvals including re-appointments of two independent directors for second five-year terms, a new independent director appointment, Audit Committee reconstitution following Mr. Kaushik Dutta's upcoming term expiry, and an amendment to ESOP 2021. All decisions are subject to shareholder approval via postal ballot, with detailed regulatory disclosures filed with stock exchanges per SEBI Listing Regulations.

powered bylight_fuzz_icon
40072381

*this image is generated using AI for illustrative purposes only.

The Board of Directors of PB Fintech Limited convened a meeting on Monday, May 11, 2026, commencing at 06:05 P.M. (IST) and concluding at 07:00 P.M. (IST). Based on the recommendations of the Nomination and Remuneration Committee, the board considered and approved several significant governance matters, all subject to shareholder approval through postal ballot.

Key Board Decisions at a Glance

The board's approvals span director re-appointments, a new appointment, committee reconstitution, and a stock option plan amendment. The following table summarises the key decisions:

Decision: Details
Re-appointment – Mrs. Veena Vikas Mankar Non-Executive Independent Director, second term of 5 years, June 19, 2026 to June 18, 2031
Re-appointment – Mr. Nilesh Bhaskar Sathe Non-Executive Independent Director, second term of 5 years, June 19, 2026 to June 18, 2031
Remuneration Approval – Mr. Dhruv Shringi Non-Executive Independent Director, June 19, 2026 to June 18, 2029
New Appointment – Ms. Jyotsana Vempati Aggarwal Additional Director (Non-Executive Independent), 5-year term from May 11, 2026
ESOP 2021 Amendment Extension of closing date of PB Fintech Employees Stock Option Plan, 2021
Audit Committee Reconstitution Effective upon expiry of Mr. Kaushik Dutta's term on June 18, 2026

Re-appointment of Independent Directors

The board approved the re-appointment of Mrs. Veena Vikas Mankar (DIN: 00004168) as a Non-Executive Independent Director for a second term of five consecutive years, effective June 19, 2026 to June 18, 2031. Mrs. Mankar holds a bachelor's degree in economics from the University of Delhi, a post graduate diploma in business administration from the Indian Institute of Management, Ahmedabad, and has completed the strategic leadership for microfinance course at Harvard Business School. She is the founder of Swadhaar FinServe Private Limited (now known as RBL FinServe Limited, a subsidiary of RBL Bank Limited), a non-executive director on the board of RBL Bank Limited, and a founder and director of Swadhaar FinAccess. She has previously served as a director on the board of Liberty General Insurance Limited and as the non-executive chairperson of IDFC Bank Limited (now known as IDFC First Bank Limited). Mrs. Mankar started her career with ICICI Limited and has worked with various financial institutions including West LB Group (Singapore) and FIM Bank (Malta). Mrs. Mankar is not related to any director of the company and is not debarred from holding the office of director by virtue of any SEBI order or any other authority.

Similarly, the board approved the re-appointment of Mr. Nilesh Bhaskar Sathe (DIN: 02372576) as a Non-Executive Independent Director for a second term of five consecutive years, effective June 19, 2026 to June 18, 2031. Mr. Sathe holds a bachelor's degree and a master's degree in commerce from Nagpur University and is a certified associate with the Indian Institute of Bankers. He has served as whole-time member of IRDAI, as CEO and Director of LIC Nomura Mutual Fund Asset Management Company, and as zonal manager (Northern Zone) of Life Insurance Corporation of India. He also worked with Bank of India and Canara Bank for over 5 years before joining LIC of India as a Direct Recruit Officer, bringing decades of experience in banking, insurance, and mutual fund industries. Mr. Sathe is not related to any director of the company and is not debarred from holding the office of director by virtue of any SEBI order or any other authority.

New Appointment: Ms. Jyotsana Vempati Aggarwal

The board approved the appointment of Ms. Jyotsana Vempati Aggarwal (DIN: 07018413) as an Additional Director in the capacity of Non-Executive Independent Director for a term of five consecutive years with effect from May 11, 2026. Ms. Aggarwal holds a bachelor's degree in Chemical Engineering from the Indian Institute of Technology, Delhi, and an MBA in Finance and Marketing from the Indian Institute of Management Lucknow. She is the co-founder and Chief Executive Officer of Wysa, a clinically validated AI platform for mental health operating across 95 countries with over 11 million users. Under her leadership, Wysa has built partnerships with national health systems including NHS England and the Singapore Ministry of Health, secured FDA Breakthrough Device Designation in the United States, and developed a clinical evidence base spanning over 40 peer-reviewed publications. Wysa is recognised as the first mental health chatbot to achieve DCB0129 clinical safety certification.

Ms. Aggarwal brings over thirty years of leadership experience across digital platforms, learning technology, and social enterprise. She served as Managing Director (International) at Pearson Learning Solutions, where she led international operations and product strategy across multiple markets, and as Founding Director of Technology and Innovation at Silatech, a Qatar Foundation initiative, where she built large-scale digital livelihoods programmes connecting over a million young people to skills and employment across the Middle East and North Africa. She is a contributor to IEEE P3962, the international standard for assessment criteria for medical mobile health applications, and has served as an expert contributor to the UNICEF Digital Support for Parents framework. She is a Professional Advisor at the MIT Kuo Sharper Center for Prosperity and Entrepreneurship, a Fellow of the Royal Society of Arts, and an Inaugural Fellow of the Bernard van Leer Foundation. She has been recognised as a Top 10 Global Innovator for Social Good by the World Economic Forum, named among Business Insider's Top 100 People in Artificial Intelligence (2023), and recognised by the Government of India as one of 75 Women Transforming India.

Her areas of expertise include:

  • Artificial intelligence governance, safety, and regulation
  • Digital platform strategy and scaled consumer technology
  • International business leadership and cross-border operations
  • Health technology, digital health distribution, and insurance-adjacent services
  • Social enterprise and stakeholder governance

Ms. Aggarwal is not related to any director of the company and is not debarred from holding the office of director by virtue of any SEBI order or any other authority.

Audit Committee Reconstitution

The board also approved the reconstitution of the Audit Committee, following the upcoming expiration of Mr. Kaushik Dutta's term as Non-Executive Independent Director and Audit Committee Chairperson on June 18, 2026, as he has not offered to renew his appointment as an Independent Director. The reconstituted Audit Committee composition is as follows:

Sr. No.: Name of Director Position in Committee Nature of Directorship
1. Mr. Dhruv Shringi Chairperson Independent Director
2. Mr. Nilesh Bhaskar Sathe Member Independent Director
3. Ms. Kitty Agarwal Member Independent Director

All the above decisions are subject to the approval of shareholders through postal ballot. The notice of postal ballot, along with the explanatory statement and related documents, will be sent to shareholders and stock exchanges in due course. The disclosures will also be hosted on the company's website at www.pbfintech.in .

Historical Stock Returns for PB FinTech

1 Day5 Days1 Month6 Months1 Year5 Years
+2.06%-2.63%+8.38%-8.40%-3.63%+36.10%

PB Fintech Analyst Day 2026: ₹670 Cr PAT in FY26, Targets ₹1,000 Cr in FY27

4 min read     Updated on 13 May 2026, 10:35 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

PB Fintech's Analyst Day 2026 presentation revealed ₹670 Cr PAT in FY26 with a ₹1,000 Cr target for FY27, underpinned by 4.8x revenue growth to ₹6,794 Cr since IPO. The company achieved 20% retail health market share, ₹31,000 Cr loan disbursals via Paisabazaar, 54% YoY UAE premium growth, and a 20% AI-driven improvement in sales conversion rates.

powered bylight_fuzz_icon
39634930

*this image is generated using AI for illustrative purposes only.

PB Fintech Limited has filed an investor presentation with the stock exchanges pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, following the Analyst Day 2026 held on May 11, 2026, at its head office in Gurugram. The presentation, signed by Bhasker Joshi, Company Secretary and Compliance Officer, has been uploaded on the company's website at https://www.pbfintech.in/pdf/pbfintech-analyst-day-2026.pdf . The event was held in physical mode at Plot No. 119, Sector-44, Gurugram-122001, Haryana, commencing at 11:00 A.M. IST. The company has set a Profit After Tax (PAT) target of ₹1,000 Crore for FY27, building on its ₹670 Cr PAT reported in FY26.

Journey Since IPO: Key Financial Milestones

The investor presentation outlined PB Fintech's performance since its IPO, highlighting substantial growth across all key financial parameters. The company turned profitable in FY24 and has continued to scale since. The following table summarises the company's progress from FY22 to FY26:

Metric: FY22 FY26 Growth
Profit After Tax: ₹(833) Cr ₹670 Cr Profitable since FY24
Total Insurance Premium: ₹6,152 Cr ₹29,934 Cr 4.9x | 49% CAGR
Total Lending Disbursal: ₹6,607 Cr ₹30,740 Cr 4.7x | 47% CAGR
Revenue: ₹1,425 Cr ₹6,794 Cr 4.8x | 48% CAGR
Renewal ARR (Core Online): ~₹260 Cr (Q4 FY22) ₹1,126 Cr (Q4 FY26) 4.4x | 45% CAGR

The company also reported renewal revenue of ₹935 Cr in FY26 with approximately 80% margins, growing at 43% CAGR since IPO, and approximately 15x since FY19 from ₹64 Cr. The company has 26.4 million unique transacting customers in insurance and 7.5 million unique transacting customers in Paisabazaar till date.

Insurance Business: Life, Health, and Motor

PB Fintech's Policybazaar platform has established itself as one of the top distribution players across life, health, and motor insurance segments. In the life insurance segment, the company reported a 4-year CAGR of 32% in fresh term and savings premium and grew at 33% in FY26, while growing at 3x the market over four years. The company drives approximately one-fourth of India's fresh term insurance market. In risk controls, PB Fintech averted ₹9,618 Cr in sum assured through its fraud detection framework in FY26, with cancellations representing 3.2% of premium and 3.6% of policies (term and savings combined). Customer satisfaction in life insurance reached 90%+, with 569 life claims assisted in FY26 and turnaround times down 32% year-on-year.

In the general insurance segment, Policybazaar emerged as the 3rd largest retail fresh health player by end of FY26, with retail health fresh market share growing 4x since IPO — from 4.5% to 20% in FY26. The company anticipates exceeding the 20% retail health market share mark in FY27. The platform added 16 lakh new lives in retail health in FY26, representing 40% of all new lives added to the industry. Health fresh business grew 68% in FY26, growing at over 3x the market rate. In motor insurance, private car market share stood at 8.6% and two-wheeler at 11.8%, with two-wheeler growing 100% year-on-year. The motor claims program reported repair turnaround time 50% lower than industry average and repair cost approximately 30% lower per claim (₹22,000 via PB versus ₹32,000 industry average), with 84% of reported claims handled by PB.

Paisabazaar: Credit Business Highlights

Paisabazaar, the company's credit marketplace, reported loan disbursals of ₹31,000 Cr and issued 3.5 lakh credit cards for the year ended March 2026. The platform recorded 25 lakh monthly enquiries for credit products and 32 lakh transactions on an annualised run-rate basis for the quarter ended March 2026. The platform has 5.8 crore credit score consumers till date and added 76 lakh new consumers in FY26, with consumer enquiries coming from 1,000+ cities.

UAE Operations and PB Partners

Policybazaar's UAE operations recorded FY26 premium growth of 54% year-on-year, with a Q4 FY26 annualised run-rate of ₹1,980 Cr, representing 12x growth since the Q4 FY22 baseline. The platform holds the #1 market position in UAE's digital insurance marketplace with a panel of 25+ insurers and a customer trust rating of 4.6 stars. PB Partners, the company's tech-led POSP (Point of Solicitation Person) platform, expanded its registered partner base by 7x versus the FY22 base of 58,000, now covering 1.7x more pin codes since FY22 and operating across 647 employee cities pan-India. The platform reported that 42% of annual premium equivalent comes from small partners, with 90%+ of partners being small partners in FY26.

AI and Technology Infrastructure

The presentation highlighted PB Fintech's AI-driven operating model embedded across sales, risk, and service functions. Key AI infrastructure metrics include a 3 TB data lake with 2,500+ daily reporting pipelines, 500 GB per day of real-time data ingestion, 2.53 crore documents with PII masking, and 100% call transcription across 7 languages via proprietary ASR technology. The AI sales stack reported a 20% improvement in conversion rate, 10% increase in average ticket size, and 30% of callbacks auto-scheduled. The company's Ask Genie AI assistant handles 100,000 queries per day, supporting approximately 20,000 advisors.

AI Impact Metric: Performance
Conversion Rate Improvement: +20%
Average Ticket Size Uplift: +10%
Callbacks Auto-Scheduled: 30%
Ask Genie Queries/Day: 100,000
Documents PII-Masked: 2.53 Cr
Data Ingestion: 500 GB/day
Call Transcription: 100% (calls >10 seconds)

The filing was submitted to both the National Stock Exchange of India Limited and BSE Limited, and the presentation is available on the company's investor relations page at https://www.pbfintech.in/investor-relations .

Historical Stock Returns for PB FinTech

1 Day5 Days1 Month6 Months1 Year5 Years
+2.06%-2.63%+8.38%-8.40%-3.63%+36.10%

Can PB Fintech sustain its 49% insurance premium CAGR trajectory beyond FY27, or will market saturation in urban centers force a slowdown as it penetrates deeper into Tier-2 and Tier-3 cities?

With Policybazaar targeting over 20% retail health market share in FY27, how might incumbent insurers and competing aggregators respond competitively, and could this trigger pricing pressure that impacts PB Fintech's margins?

Given the UAE operation's 12x growth since FY22, which other international markets is PB Fintech likely to prioritize for expansion, and what regulatory or competitive barriers could limit its global ambitions?

More News on PB FinTech

1 Year Returns:-3.63%